
Loading, please wait...

Loading, please wait...

A prospective comparative study evaluated endoscopic endonasal dacryocystorhinostomy (DCR) against external DCR for acquired partial nasolacrimal duct obstruction. Both procedures aim to bypass the obstructed drainage pathway and establish a functional connection between the lacrimal sac and nasal cavity, but they differ in incision, nasal access, visualization, and postoperative management. The study is relevant to oculoplastic practice because procedure choice often depends on the anatomy of the obstruction, nasal findings, surgeon expertise, and patient priorities. Endoscopic approaches avoid a facial skin incision and allow direct nasal visualization, while external DCR remains a widely established and highly effective technique. The evidence does not support treating the approaches as competitors with a single universal winner. Instead, both can be appropriate depending on the clinical scenario. For HCP education, the paper is a useful reminder to separate anatomical success from patient-centered considerations such as scar concerns, operative time, nasal pathology, and the need for adjunctive procedures. Preoperative imaging or lacrimal assessment should be integrated where indicated to clarify the level and nature of obstruction before selecting the surgical route.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A prospective comparative study evaluated endoscopic endonasal dacryocystorhinostomy (DCR) against external DCR for acquired partial nasolacrimal duct obstruction. Both procedures aim to bypass the obstructed drainage pathway and establish a functional connection between the lacrimal sac and nasal cavity, but they differ in incision, nasal access, visualization, and postoperative management. The study is relevant to oculoplastic practice because procedure choice often depends on the anatomy of the obstruction, nasal findings, surgeon expertise, and patient priorities. Endoscopic approaches avoid a facial skin incision and allow direct nasal visualization, while external DCR remains a widely established and highly effective technique. The evidence does not support treating the approaches as competitors with a single universal winner. Instead, both can be appropriate depending on the clinical scenario. For HCP education, the paper is a useful reminder to separate anatomical success from patient-centered considerations such as scar concerns, operative time, nasal pathology, and the need for adjunctive procedures. Preoperative imaging or lacrimal assessment should be integrated where indicated to clarify the level and nature of obstruction before selecting the surgical route.
Today

The phase 3 ACACIA-HCM trial reveals that aficamten improves cardiac structure, diastolic relaxation, functional capacity, and symptom burden in symptomatic nonobstructive hypertrophic cardiomyopathy, marking a major milestone in targeted myosin inhibition.
6 days back

A clinical study shows that automated breast ultrasound paired with artificial intelligence accurately classifies BIRADS 3-4 lesions, reaching 95% sensitivity and 79% specificity. This diagnostic advance promises to reduce unnecessary core needle biopsies and refine clinical workflows in breast imaging.
3 weeks back

Researchers have engineered freestanding hierarchical-porous BCZT thin films that resist cracking and enhance ultrasonic energy harvesting in soft tissue. Achieving high piezoelectric output and acoustic matching, this lead-free material offers transformative potential for implantable bioelectronics.
6 days back

A novel pathology-adaptive surface engineering strategy uses functionalized plasma polymer coatings to selectively modulate AGE adsorption, reducing oxidative stress and restoring bone formation in diabetic and aging microenvironments.
3 weeks back

A breakthrough study identifies the Klotho/PKCα/CUX1/SPARC/TGFβ-RII axis as a critical driver of podocyte mitochondrial injury and ferroptosis in diabetic kidney disease, unveiling promising molecular targets to halt renal disease progression.
6 days back